about
PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical StatusUpdate on positron emission tomography for imaging of prostate cancerBiomarkers in preclinical cancer imaging.Update on advances in molecular PET in urological oncologyMagnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands.Optimization of Acquisition time of 68Ga-PSMA-Ligand PET/MRI in Patients with Local and Metastatic Prostate Cancer.Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.Tracing the nitrogen metabolites of glycine using (15)N-glycine and mass spectrometry.The clinical role of multimodality imaging in the detection of prostate cancer recurrence after radical prostatectomy and radiation therapy: past, present, and futurePretargeted immunoPET of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody in mice with PC3 xenografts.FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy.11C-Choline-Avid but 18F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography.An Incidental Finding of Mucinous Colon Cancer by (18)F-Choline PET/CT Determining a Change in Clinical Management of a Patient with Recurrent Prostate Adenocarcinoma.Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [68Ga]-Labeled Glu-Urea-Lys(Ahx)-HBED-CC (Positron Emission Tomography) Tracer.Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.Value of bimodal (18)F-choline-PET/MRI and trimodal (18)F-choline-PET/MRI/TRUS for the assessment of prostate cancer recurrence after radiation therapy and radical prostatectomy.Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by 11C-Choline PET/CT.
P2860
Q26774920-D86536A9-496F-40F8-8665-E2CB9483B7D4Q27026828-F0CC020F-B59B-4A02-9A54-AEC4747BF110Q30416864-FFEF679D-B51E-4775-8817-8390321DEB09Q33625389-E2E103BC-7DC2-4587-80B4-36A5E90B33ECQ34172827-189427EA-DD81-46AF-BBCD-C69627330294Q36166095-10E5EA9C-40E4-45A7-B112-11130065E2E0Q38564109-3719C096-DC5F-471B-836D-88BDC63A4E37Q38802235-B38D6BCD-E56E-4558-A084-FCF00B587178Q38814811-8B14BB24-F15B-4561-8642-6EF50D176B39Q38849124-CC7298B9-DF56-45C5-ABA8-32B5C00A65C5Q38956835-B9F7B98F-8B94-40DC-A86D-8DCC1193BFDBQ38971971-4ADE507B-384D-4788-8647-1CB94182BFD6Q42117913-E1451424-F95D-49A2-825A-AADB9C8320CCQ42362421-65723DBC-031F-421F-A844-05A19365EDF6Q42843725-EA2F130F-1D01-41E4-B910-569EA555463DQ47135640-7023DC4D-4B77-43B2-AE64-D1145A460CD9Q52665542-15FA0E74-2A28-4B8B-B80A-DF5FA66098F2Q52960162-B3A69016-EA51-4CEE-8E30-9C2727C4D229Q53031184-CB987986-0571-4E0E-B07D-74F84D111AB0Q55405488-C4ECF641-B02F-4B7F-9CEE-C85DCEA3B2FD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Choline PET/CT for imaging prostate cancer: an update.
@en
type
label
Choline PET/CT for imaging prostate cancer: an update.
@en
prefLabel
Choline PET/CT for imaging prostate cancer: an update.
@en
P2860
P1476
Choline PET/CT for imaging prostate cancer: an update.
@en
P2093
Kazuhiro Kitajima
Mark A Nathan
P2860
P2888
P304
P356
10.1007/S12149-013-0731-7
P577
2013-04-30T00:00:00Z
P6179
1036055232